Phase 2 Lymphoma Trial, Recruiting

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who have been diagnosed with a slow-growing (indolent) type of lymphoma, such as marginal-zone B-cell lymphoma, Waldenström macroglobulinemia, CLL/SLL, or mantle cell lymphoma.
• People who have already had, or are planned to have, a specific type of scan called an FDG PET scan (used to look at disease activity in the body) for reasons such as initial staging, checking how treatment is working, or follow-up monitoring — within a 3 to 6 month window in the observation group.
• People who are able to lie still and flat for at least 30 minutes.
• People who are willing to sign a consent form agreeing to take part in the study.
• People with a general health and activity level rated as ECOG grade 0–2, meaning they are fully active or have only minor limitations in daily activities (confirm with trial site).
• People whose use of the FDG scan tracer fits within the lymphoma treatment guidelines used at the trial institution (confirm with trial site).

Who may not be able to join:

• People who are pregnant.
• People with severely reduced kidney function (an eGFR below 30 ml/min).
• People with a known or suspected allergy to radioactive imaging substances (radiopharmaceuticals).
• People who have been diagnosed with another type of cancer, either at the same time or in the past, separate from their lymphoma.
• People who are unable to undergo the PET scan procedure required by the study.
• People who are unwilling or refuse to sign the consent form.
• People with serious medical conditions, including severe physical disabilities or mental health disorders.

Important: Always verify eligibility with the trial site directly before applying.